Understanding the Determinants of Use of the Australian Guide to Diagnosis of Fetal Alcohol Spectrum Disorder: Informing the Review, Development and Dissemination of New National Clinical Practice Guidelines
Drug and Alcohol Review · 2025
DOI: 10.1111/dar.70030 ↗Kurz gefasst
Leitlinie in der Zeitschrift Drug and Alcohol Review, 2025. Verfasst von Natasha Reid und 6 weiteren Autor:innen. Beteiligte Einrichtung: Child Health Research Centre, The University of Queensland, Brisbane, Australia. Hauptthemen laut MEDLINE: Fetal Alcohol Spectrum Disorders, Practice Guidelines as Topic. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Australian Department of Health and Aged Care, University of Sydney, Department of Health and Aged Care, Australian Government.
Abstract (Originalsprache)
Introduction
The Australian Guide to the Diagnosis of fetal alcohol spectrum disorder (FASD), developed in 2016, is currently under review. This study aimed to understand how the Guide is used in practice and identify factors influencing its implementation.
Methods
A cross‐sectional online survey was conducted with Australian health practitioners involved in the assessment and diagnosis of FASD. The Clinician Guideline Determinants Questionnaire was used. Quantitative data were summarised descriptively and content analysis was applied to open‐ended questions.
Results
Of 333 survey sessions, 232 participants consented and 136 completed the survey. Most respondents were paediatricians ( n = 54, 37%) or psychologists ( n = 49, 33%). Although most clinicians felt confident using the Guide, only 44.1% agreed it clearly described the underlying evidence, and just 21% felt it adequately reflected patient preferences. Key enablers included clear, easy‐to‐follow guidance ( n = 45, 36.3%); ease of access ( n = 18, 14.5%) and familiarity with the Guide ( n = 14, 11.3%). Common barriers were lack of access to appropriate clinicians, time and cost constraints ( n = 25, 24.8%); concerns about the evidence base ( n = 16, 15.8%); and lack of familiarity or skills ( n = 8, 7.9%). Discussion and Conclusions Findings highlight strong clinician engagement with the 2016 Guide but also identify areas for improvement, particularly around evidence transparency and alignment with person‐centred care. By engaging with stakeholders and improving guidelines based on clinician feedback, we can improve the quality of care and support for individuals with FASD and their families.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Child Health Research Centre, The University of Queensland, Brisbane, Australia.
- School of Psychology, The University of Queensland, Brisbane, Australia.
- Health Evidence Synthesis, Recommendations, and Impact, School of Public Health, Adelaide University, Adelaide, Australia.
- School of Education, Queensland University of Technology, Brisbane, Australia.
ORCID-Profile: Natasha Reid
Förderung
- Australian Department of Health and Aged Care
- University of Sydney
- Department of Health and Aged Care, Australian Government
Zitieren
APA
Reid, N., Logan, J., Wong, Y., Munn, Z., Vanderpeet, C., Hayes, N., & Australian FASD Guidelines Consortium (2025). Understanding the Determinants of Use of the Australian Guide to Diagnosis of Fetal Alcohol Spectrum Disorder: Informing the Review, Development and Dissemination of New National Clinical Practice Guidelines. Drug and Alcohol Review. https://doi.org/10.1111/dar.70030
Vancouver
Reid N, Logan J, Wong Y, Munn Z, Vanderpeet C, Hayes N, et al. Understanding the Determinants of Use of the Australian Guide to Diagnosis of Fetal Alcohol Spectrum Disorder: Informing the Review, Development and Dissemination of New National Clinical Practice Guidelines. Drug and Alcohol Review. 2025. doi:10.1111/dar.70030
BibTeX
@article{Reid2025,
author = {Reid, Natasha and Logan, Jayden and Wong, Yasmine and Munn, Zachary and Vanderpeet, Chelsea and Hayes, Nicole and Australian FASD Guidelines Consortium, Australian FASD Guidelines Consortium},
title = {Understanding the Determinants of Use of the Australian Guide to Diagnosis of Fetal Alcohol Spectrum Disorder: Informing the Review, Development and Dissemination of New National Clinical Practice Guidelines},
journal = {Drug and Alcohol Review},
year = {2025},
doi = {10.1111/dar.70030}
}
EUVIMED